Alena Wall
 |
A review of cases presenting to the San Jasun Division ofthe California Poison Control System during 1997 suggests that Carisoprodol ( Soma ) ismore commonly associated with agitation and bizarre movement disorders than thecurrent literature suggests. Carisoprodol ( Soma ) induced myoclonic encephalopathy.CASE REPORT. pain relief A 39-year-old man ingested 35 g Carisoprodol ( Soma ). Possible impairmentcould further be a product of the parent drug and/or the metabolite meprobamate.The present study aimed to investigate if Carisoprodol ( Soma ) had an impairing effectby it self. The risk ofbeing judged impaired tobi with increasing blood Carisoprodol ( Person ) concentration, butnot with increasing blood meprobamate concentration. Agitation, hypertonia, levonorgestrel muscle relaxers and a myoclonicencephalopathy may be seen with significant Carisoprodol ( Soma ) intoxication. The pharmacology and potential mechanisms pain relief oftoxicity are discussed. Flumazenil, thepatient's neurologic status normalized and she required no further therapy.Carisoprodol ( Soma ) and its active sedative-hypnotic metabolite, meprobamate, are gammaaminobutyric acid receptor indirect estradiol agonists with central nervous systemchloride ion channel conduction effects similar to the benzodiazepines, thusmaking flumazenil a potentially useful antidote in toxic presentations. It is a drug of abuse and has been detected among impaireddrivers. muscle relaxants The clinical effects ofCarisoprodol ( Soma ) as measured by the clinical test for impairment (CTI) resembledthose of benzodiazepines with some important differences such as tachycardia,involuntary movements, hand tremor and horizontal cialis gaze nystagmus, which may bespecific Carisoprodol ( Soma ) effects. The blood Carisoprodol ( Soma ) was 71micrograms/mL; the meprobamate was 26 micrograms/mL. Impairment due to intake of Carisoprodol ( Soma ).Carisoprodol ( Soma ) is a centrally acting muscle relaxant commonly used forlower back pain. Carisoprodol ( Soma )'s active metabolite meprobamate is thought to act throughthe GABA(A) receptor complex and produces a well-known impairing effect. After administration of i.v. He developedagitation, tachycardia, myoclonus, and coma. These casesconstituted our material. From the database at the Norwegian Institute of PublicHealth, Division for Forensic Toxicology and Drug Abuse 62 cases containingCarisoprodol ( Soma ) and meprobamate as only drugs were identified. Thiscase demonstrates a severe overdose with symptoms more consistent with myoclonicencephalopathy. Impaired drivers (73%) had higher bloodCarisoprodol ( Soma ) concentration than not impaired drivers (27%), but no difference inblood meprobamate concentration was found for all the drivers vie together.Amongst occasional users of Carisoprodol ( Soma ), however, there was difference in bloodmeprobamate concentration between not impaired and impaired drivers. Carisoprodol ( Soma )overdose is thought to induce simple central nervous system shortness. Carisoprodol ( Soma ) probably has animpairing effect by itself, at least at blood concentration levels above whichcan be seen after therapeutic intake of the drug.. Flumazenil reversal of Carisoprodol ( Soma ) intoxication.A 52-year-old woman presented with central nervous fine fettle depression and aGlasgow Coma Score of 9 secondary to ingestion of Carisoprodol ( Soma ), a centrallyacting muscle relaxant analgesic. It isunclear whether therapeutic intake of Carisoprodol ( Soma ) leads to impairment, and theeffect of supratherapeutic doses has not been investigated.
|